Notably, these results indicated that both DCLK1-A and DCLK1-B play a critical role in CRC aggressiveness, and this observation prompted us to focus on the kinase domain that is common to both DCLK1-A and DCLK1-B. Here, DCLK1 is linked to colorectal carcinoma.